Cargando…

A Population-Based Study of the Risk of Diabetic Retinopathy in Patients With Type 1 Diabetes and Celiac Disease

OBJECTIVE: Celiac disease (CD) is associated with type 1 diabetes (T1D). In the current study, we examined whether CD affects the risk of diabetic retinopathy (DRP) in patients with T1D. RESEARCH DESIGN AND METHODS: This was a population-based cohort study. Through the Swedish National Patient Regis...

Descripción completa

Detalles Bibliográficos
Autores principales: Mollazadegan, Kaziwe, Kugelberg, Maria, Montgomery, Scott M., Sanders, David S., Ludvigsson, Johnny, Ludvigsson, Jonas F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554314/
https://www.ncbi.nlm.nih.gov/pubmed/22966098
http://dx.doi.org/10.2337/dc12-0766
_version_ 1782256874264985600
author Mollazadegan, Kaziwe
Kugelberg, Maria
Montgomery, Scott M.
Sanders, David S.
Ludvigsson, Johnny
Ludvigsson, Jonas F.
author_facet Mollazadegan, Kaziwe
Kugelberg, Maria
Montgomery, Scott M.
Sanders, David S.
Ludvigsson, Johnny
Ludvigsson, Jonas F.
author_sort Mollazadegan, Kaziwe
collection PubMed
description OBJECTIVE: Celiac disease (CD) is associated with type 1 diabetes (T1D). In the current study, we examined whether CD affects the risk of diabetic retinopathy (DRP) in patients with T1D. RESEARCH DESIGN AND METHODS: This was a population-based cohort study. Through the Swedish National Patient Register, we identified 41,566 patients diagnosed with diabetes in 1964–2009 and who were ≤30 years of age at diagnosis. CD was defined as having villous atrophy (Marsh stage 3) according to small intestinal biopsies performed between 1969 and 2008, with biopsy reports obtained from Sweden’s 28 pathology departments. During follow-up, 947 T1D patients had a diagnosis of CD. We used Cox regression analysis with CD as a time-dependent covariate to estimate adjusted hazard ratios (aHRs) for DRP in patients with T1D and CD and compared them with patients with T1D but no CD. RESULTS: Duration of CD correlated with the risk of DRP. When results were stratified by time since CD diagnosis, individuals with T1D and CD were at a lower risk of DRP in the first 5 years after CD diagnosis (aHR 0.57 [95% CI 0.36–0.91]), followed by a neutral risk in years 5 to <10 (1.03 [0.68–1.57]). With longer follow-up, coexisting CD was a risk factor for DRP (10 to <15 years of follow-up, aHR 2.83 [95% CI 1.95–4.11]; ≥15 years of follow-up, 3.01 [1.43–6.32]). CONCLUSIONS: Having a diagnosis of CD for >10 years is a risk factor for the development of DRP in T1D. Long-standing CD in patients with T1D merits intense monitoring of DRP.
format Online
Article
Text
id pubmed-3554314
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-35543142014-02-01 A Population-Based Study of the Risk of Diabetic Retinopathy in Patients With Type 1 Diabetes and Celiac Disease Mollazadegan, Kaziwe Kugelberg, Maria Montgomery, Scott M. Sanders, David S. Ludvigsson, Johnny Ludvigsson, Jonas F. Diabetes Care Original Research OBJECTIVE: Celiac disease (CD) is associated with type 1 diabetes (T1D). In the current study, we examined whether CD affects the risk of diabetic retinopathy (DRP) in patients with T1D. RESEARCH DESIGN AND METHODS: This was a population-based cohort study. Through the Swedish National Patient Register, we identified 41,566 patients diagnosed with diabetes in 1964–2009 and who were ≤30 years of age at diagnosis. CD was defined as having villous atrophy (Marsh stage 3) according to small intestinal biopsies performed between 1969 and 2008, with biopsy reports obtained from Sweden’s 28 pathology departments. During follow-up, 947 T1D patients had a diagnosis of CD. We used Cox regression analysis with CD as a time-dependent covariate to estimate adjusted hazard ratios (aHRs) for DRP in patients with T1D and CD and compared them with patients with T1D but no CD. RESULTS: Duration of CD correlated with the risk of DRP. When results were stratified by time since CD diagnosis, individuals with T1D and CD were at a lower risk of DRP in the first 5 years after CD diagnosis (aHR 0.57 [95% CI 0.36–0.91]), followed by a neutral risk in years 5 to <10 (1.03 [0.68–1.57]). With longer follow-up, coexisting CD was a risk factor for DRP (10 to <15 years of follow-up, aHR 2.83 [95% CI 1.95–4.11]; ≥15 years of follow-up, 3.01 [1.43–6.32]). CONCLUSIONS: Having a diagnosis of CD for >10 years is a risk factor for the development of DRP in T1D. Long-standing CD in patients with T1D merits intense monitoring of DRP. American Diabetes Association 2013-02 2013-01-17 /pmc/articles/PMC3554314/ /pubmed/22966098 http://dx.doi.org/10.2337/dc12-0766 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Original Research
Mollazadegan, Kaziwe
Kugelberg, Maria
Montgomery, Scott M.
Sanders, David S.
Ludvigsson, Johnny
Ludvigsson, Jonas F.
A Population-Based Study of the Risk of Diabetic Retinopathy in Patients With Type 1 Diabetes and Celiac Disease
title A Population-Based Study of the Risk of Diabetic Retinopathy in Patients With Type 1 Diabetes and Celiac Disease
title_full A Population-Based Study of the Risk of Diabetic Retinopathy in Patients With Type 1 Diabetes and Celiac Disease
title_fullStr A Population-Based Study of the Risk of Diabetic Retinopathy in Patients With Type 1 Diabetes and Celiac Disease
title_full_unstemmed A Population-Based Study of the Risk of Diabetic Retinopathy in Patients With Type 1 Diabetes and Celiac Disease
title_short A Population-Based Study of the Risk of Diabetic Retinopathy in Patients With Type 1 Diabetes and Celiac Disease
title_sort population-based study of the risk of diabetic retinopathy in patients with type 1 diabetes and celiac disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554314/
https://www.ncbi.nlm.nih.gov/pubmed/22966098
http://dx.doi.org/10.2337/dc12-0766
work_keys_str_mv AT mollazadegankaziwe apopulationbasedstudyoftheriskofdiabeticretinopathyinpatientswithtype1diabetesandceliacdisease
AT kugelbergmaria apopulationbasedstudyoftheriskofdiabeticretinopathyinpatientswithtype1diabetesandceliacdisease
AT montgomeryscottm apopulationbasedstudyoftheriskofdiabeticretinopathyinpatientswithtype1diabetesandceliacdisease
AT sandersdavids apopulationbasedstudyoftheriskofdiabeticretinopathyinpatientswithtype1diabetesandceliacdisease
AT ludvigssonjohnny apopulationbasedstudyoftheriskofdiabeticretinopathyinpatientswithtype1diabetesandceliacdisease
AT ludvigssonjonasf apopulationbasedstudyoftheriskofdiabeticretinopathyinpatientswithtype1diabetesandceliacdisease
AT mollazadegankaziwe populationbasedstudyoftheriskofdiabeticretinopathyinpatientswithtype1diabetesandceliacdisease
AT kugelbergmaria populationbasedstudyoftheriskofdiabeticretinopathyinpatientswithtype1diabetesandceliacdisease
AT montgomeryscottm populationbasedstudyoftheriskofdiabeticretinopathyinpatientswithtype1diabetesandceliacdisease
AT sandersdavids populationbasedstudyoftheriskofdiabeticretinopathyinpatientswithtype1diabetesandceliacdisease
AT ludvigssonjohnny populationbasedstudyoftheriskofdiabeticretinopathyinpatientswithtype1diabetesandceliacdisease
AT ludvigssonjonasf populationbasedstudyoftheriskofdiabeticretinopathyinpatientswithtype1diabetesandceliacdisease